Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-172 hepatic impairment pharmacokinetic study
jRCT2031250445Recruiting
- Sponsor
- Taisho Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of TS-172 in hyperphosphatemia (3 arms), sponsored by Taisho Pharmaceutical. Primary endpoint: Plasma concentrations of unchanged form and metabolites. Started Dec 2025; status: recruiting.
02
Drugs
TS-172
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on jRCT2031250445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250445.